Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+45.1%
5Y CAGR+152.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+45.1%/yr
Annual compound
5Y CAGR
+152.3%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
102.3x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $138.19M | +21.2% |
| 2024 | $114.02M | +86.5% |
| 2023 | $61.14M | +35.2% |
| 2022 | $45.24M | +521.5% |
| 2021 | $7.28M | +438.8% |
| 2020 | $1.35M | +45.9% |
| 2019 | $926000.00 | - |